Compare · CBUS vs SNES
CBUS vs SNES
Side-by-side comparison of Cibus Inc. (CBUS) and SenesTech Inc. (SNES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBUS and SNES operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- CBUS is the larger of the two at $136.6M, about 18.1x SNES ($7.5M).
- Over the past year, CBUS is up 6.5% and SNES is down 68.7% - CBUS leads by 75.3 points.
- SNES has hit the wire 5 times in the past 4 weeks while CBUS has been quiet.
- CBUS has more recent analyst coverage (4 ratings vs 0 for SNES).
PerformanceCBUS+6.55%SNES-68.73%
2025-07-21+0.00%2026-07-17
- Company
- Cibus Inc.
- SenesTech Inc.
- Price
- $1.79-1.65%
- $1.39-2.46%
- Market cap
- $136.6M
- $7.5M
- 1M return
- +36.64%
- -13.66%
- 1Y return
- +6.55%
- -68.73%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2016
- News (4w)
- 0
- 5
- Recent ratings
- 4
- 0
SNES
SenesTech Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest CBUS
- SEC Form S-8 filed by Cibus Inc.
- SEC Form S-8 filed by Cibus Inc.
- Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
- CEO Wichner Craig was granted 894,309 shares (SEC Form 4)
- Cibus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
- Cibus Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Finn Mark Terrence
- SEC Form 4 filed by Director Moretti August J
- SEC Form 4 filed by Director Riggs Rory B
Latest SNES
- SenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural Operation
- Chief Executive Officer Edell Michael bought $1,430 worth of shares (1,000 units at $1.43), increasing direct ownership by 25% to 5,000 units (SEC Form 4)
- Large owner Glenbrook Capital Management bought $52,731 worth of shares (35,000 units at $1.51) (SEC Form 4)
- Large owner Glenbrook Capital Management bought $39,102 worth of shares (25,416 units at $1.54) (SEC Form 4)
- SenesTech Appoints Jack Karabees as Executive Vice President of Sales
- Large owner Glenbrook Capital Management bought $13,563 worth of shares (8,264 units at $1.64) (SEC Form 4)
- SEC Form 4 filed by Director Moss Joshua Matthew
- SEC Form 4 filed by Director Leach Jacob Steven
- SEC Form 4 filed by Director Grandinetti Phillip Nicholas Iii
- SEC Form 4 filed by Director Szot Matthew K